跳至主要内容
临床试验/JPRN-jRCT1080220348
JPRN-jRCT1080220348未知4 期

A Study to Evaluate the Efficacy and Safety of Rosuvastatin in the Long-Term Treatment of Hypercholesterolaemic Subjects With Coronary Heart Disease as Measured by Intravascular Ultrasonography

AstraZeneca/Shionogi0 个研究点开始时间: 2007年1月31日最近更新:
适应症

试验速览

阶段
4 期
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
>= 20age old 至 <= 75age old(—)
性别
All

入选标准

  • Ages Eligible for Study: 20 Years - 75 Years
  • Genders Eligible for Study: Both
  • Inclusion Criteria:
  • - Signed written informed consent,
  • - 20 to 75 years old,
  • - Plan to undergo coronary angiography (CAG) or PCI and LDL-C = 140 mg/dL (untreated patients) or LDL-C =100 mg/dL (treated patients

排除标准

  • - Acute myocardial infarction within 72 hours after the onset,
  • - Heart failure of NYHA Class III or above,
  • - Serious arrhythmia,
  • - Being treated with LDL-apheresis
  • - History of serious reaction or hypersensitivity to other HMG-CoA reductase inhibitors.

研究者

发起方
AstraZeneca/Shionogi

相似试验